|
October
Tuesday, Oct 14, 2008 Genentech Announces Third Quarter 2008 Results Monday, Oct 06, 2008 Phase III Study Showed Rituxan in Combination with Chemotherapy Improved Progression-Free Survival in Patients with Relapsed Chronic Lymphocytic Leukemia Sunday, Oct 05, 2008 Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer Thursday, Oct 02, 2008 Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient Thursday, Oct 02, 2008 Genentech, Glycart and Roche Enter Into Collaboration Agreement for Potential Cancer Therapy September Tuesday, Sep 23, 2008 Genentech Announces October 14 Webcast of Financial and Other Business Results Wednesday, Sep 10, 2008 Genentech Announces Vice President Appointment In Research August Wednesday, Aug 13, 2008 Genentech Special Committee of Independent Directors Responds to Roche Proposal July Thursday, Jul 24, 2008 Genentech Forms Special Committee of Independent Directors to Review Roche Proposal Monday, Jul 21, 2008 Genentech Announces Receipt of Proposal From Roche See the Archives 
 |
